Medigus Ltd.
Simbol: MDGS
NASDAQ
2.745
USDTržna cena danes
-0.2062
Razmerje P/E
-0.0022
Razmerje PEG
4.67M
Kapaciteta MRK
- 0.00%
Donos DIV
Medigus Ltd. (MDGS) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 79.33 | 25.1 | 27.3 | 22.4 | ||||||||||
balance-sheet.row.short-term-investments | 8.11 | 5 | 3.3 | 0 | ||||||||||
balance-sheet.row.net-receivables | 94.87 | 25.2 | 1.7 | 0.3 | ||||||||||
balance-sheet.row.inventory | 8.67 | 1.8 | 1.2 | 0.2 | ||||||||||
balance-sheet.row.other-current-assets | 21.11 | 0.2 | 0.3 | 0.4 | ||||||||||
balance-sheet.row.total-current-assets | 197.6 | 52.3 | 31.7 | 24 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 3.82 | 1 | 0.1 | 0.4 | ||||||||||
balance-sheet.row.goodwill | 36.23 | 9.1 | 0.9 | 0.3 | ||||||||||
balance-sheet.row.intangible-assets | 87.71 | 21.8 | 7.4 | 0.5 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 123.94 | 30.9 | 8.3 | 0.5 | ||||||||||
balance-sheet.row.long-term-investments | 39.56 | 13.1 | 18.8 | 6.2 | ||||||||||
balance-sheet.row.tax-assets | 0.85 | 0.4 | 0 | 0 | ||||||||||
balance-sheet.row.other-non-current-assets | -83.66 | 0 | 0.8 | 1.2 | ||||||||||
balance-sheet.row.total-non-current-assets | 168.18 | 45.4 | 28.1 | 8.3 | ||||||||||
balance-sheet.row.other-assets | 0.85 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 366.64 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.account-payables | 78.02 | 20.4 | 0.7 | 0.1 | ||||||||||
balance-sheet.row.short-term-debt | 14.76 | 6.7 | 0.9 | 0.1 | ||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.long-term-debt-total | 12.98 | 3.4 | 0.7 | 0 | ||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 2.6 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3.56 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 49.74 | 10.4 | 4.9 | 3.2 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 16.68 | 5.3 | 1.7 | 2.6 | ||||||||||
balance-sheet.row.other-liabilities | 4.67 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 1.25 | 0.6 | 0 | 0.1 | ||||||||||
balance-sheet.row.total-liab | 168.36 | 43 | 8.3 | 6.1 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 93 | ||||||||||
balance-sheet.row.retained-earnings | -358.74 | -85.6 | -74.2 | -81 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 26.97 | 13.2 | 12.6 | 10.7 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 473.58 | 111.5 | 110.8 | 0.2 | ||||||||||
balance-sheet.row.total-stockholders-equity | 141.81 | 39.1 | 49.2 | 23 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 183.32 | 97.7 | 59.7 | 32.3 | ||||||||||
balance-sheet.row.minority-interest | 56.46 | 15.5 | 2.2 | 3.2 | ||||||||||
balance-sheet.row.total-equity | 198.27 | 54.7 | 51.4 | 26.2 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 183.32 | - | - | - | ||||||||||
Total Investments | 47.67 | 18.1 | 22.2 | 6.2 | ||||||||||
balance-sheet.row.total-debt | 21.73 | 10.1 | 1.6 | 0.1 | ||||||||||
balance-sheet.row.net-debt | -43.12 | -9.9 | -22.4 | -22.3 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -21.79 | -10.1 | 4.2 | -6.8 | |||||||||||
cash-flows.row.depreciation-and-amortization | 5.1 | 3.2 | 0.3 | 0.2 | |||||||||||
cash-flows.row.deferred-income-tax | -5.51 | 0.4 | -12.8 | -1.1 | |||||||||||
cash-flows.row.stock-based-compensation | 0.63 | 0.8 | 2.4 | 1.4 | |||||||||||
cash-flows.row.change-in-working-capital | -2.08 | -1.1 | 0.1 | -0.3 | |||||||||||
cash-flows.row.account-receivables | -3.62 | -7.8 | -0.2 | -0.1 | |||||||||||
cash-flows.row.inventory | -1.09 | -0.6 | -0.6 | -0.5 | |||||||||||
cash-flows.row.account-payables | 3.64 | 5.8 | 1 | 0.1 | |||||||||||
cash-flows.row.other-working-capital | -1.01 | 1.4 | -0.1 | 0.2 | |||||||||||
cash-flows.row.other-non-cash-items | 14.17 | 1.2 | 0.6 | 0.5 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -9.5 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.acquisitions-net | -2.92 | -2.4 | -7.7 | -1.3 | |||||||||||
cash-flows.row.purchases-of-investments | -2.86 | -6.6 | -0.2 | -1.8 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 1.24 | 0.5 | 1.9 | 3.1 | |||||||||||
cash-flows.row.other-investing-activites | -5.45 | 4.1 | -6.2 | -1.3 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -11.79 | -4.5 | -12.4 | -1.6 | |||||||||||
cash-flows.row.debt-repayment | -3.32 | -4.7 | -1.5 | 0 | |||||||||||
cash-flows.row.common-stock-issued | 13.25 | 12.6 | 18.7 | 23 | |||||||||||
cash-flows.row.common-stock-repurchased | -2.38 | 0 | 0 | -22.9 | |||||||||||
cash-flows.row.dividends-paid | -7.11 | -4.2 | 0 | -0.1 | |||||||||||
cash-flows.row.other-financing-activites | 1.72 | 1.8 | 1.9 | 0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.18 | 5.4 | 19.1 | 22.9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.88 | 0.8 | 0.2 | 0.1 | |||||||||||
cash-flows.row.net-change-in-cash | -14.71 | -4 | 1.7 | 15.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 50.04 | 20.1 | 24 | 22.4 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 64.75 | 24 | 22.4 | 7 | |||||||||||
cash-flows.row.operating-cash-flow | -9.5 | -5.7 | -5.3 | -6.1 | |||||||||||
cash-flows.row.capital-expenditure | -1.8 | -0.1 | -0.1 | -0.3 | |||||||||||
cash-flows.row.free-cash-flow | -11.29 | -5.7 | -5.4 | -6.5 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 166.86 | 91.9 | 10.1 | 0.5 | |||||||||||
income-statement-row.row.cost-of-revenue | 141.96 | 77.4 | 5.3 | 1 | |||||||||||
income-statement-row.row.gross-profit | 24.9 | 14.5 | 4.8 | -0.5 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 8.23 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 16.81 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 40.69 | 23 | 13 | 7 | |||||||||||
income-statement-row.row.cost-and-expenses | 182.65 | 100.4 | 18.3 | 8 | |||||||||||
income-statement-row.row.interest-income | 2.49 | 2.3 | 0.3 | 0.2 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 3.76 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0.5 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | -5.75 | 3.7 | 12.3 | 0.5 | |||||||||||
income-statement-row.row.interest-expense | 2.53 | -4.1 | 0.3 | 0 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 5.1 | 1.8 | -14 | -0.5 | |||||||||||
income-statement-row.row.ebitda-caps | -9.36 | - | - | - | |||||||||||
income-statement-row.row.operating-income | -14.45 | -13.8 | -8.2 | -7.4 | |||||||||||
income-statement-row.row.income-before-tax | -20.2 | -10.1 | 4.2 | -6.8 | |||||||||||
income-statement-row.row.income-tax-expense | 0.42 | 0.1 | 0.1 | 0 | |||||||||||
income-statement-row.row.net-income | -21.79 | -10.2 | 4 | -6.8 |
Pogosto zastavljeno vprašanje
Kaj je Medigus Ltd. (MDGS) skupna sredstva?
Medigus Ltd. (MDGS) skupna sredstva so 97651000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 80077500.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.150.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -5.754.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -0.135.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -0.086.
Kaj je Medigus Ltd. (MDGS) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -10208000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 10135000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 23033000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 12359000.000.